Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Imbruvica
Imbruvica
Janssen seeks EMA nod for Imbruvica, rituximab combo in previously untreated CLL
Pharmaceutical Business Review
Mon, 01/20/20 - 10:57 am
Janssen
JNJ
EMA
Imbruvica
CLL
Leukemia rivals try to stay ahead as Merck, Lilly chase
Biopharma Dive
Tue, 12/10/19 - 11:53 pm
Merck
Eli Lilly
AbbVie
JNJ
Imbruvica
ARQ 531
LOXO-305
CLL
ASH2019
ASH19: AZ’s Calquence throws gauntlet down to Imbruvica
Pharmaforum
Sun, 12/8/19 - 10:17 pm
AstraZeneca
cancer
Calquence
ASH2019
Imbruvica
JNJ
AbbVie
CLL
AstraZeneca's Calquence steps up to challenge Imbruvica with big CLL green light
Fierce Pharma
Thu, 11/21/19 - 06:26 pm
AstraZeneca
Calquence
Imbruvica
CLL
JNJ
AbbVie
AbbVie submits sNDA to FDA for IMBRUVICA, Rituximab combo for CLL
Pharmaceutical Business Review
Mon, 11/11/19 - 10:58 am
AbbVie
Imbruvica
rituximab
CLL
SLL
3 Most Important Takeaways From AbbVie's Q3 Results
Motley Fool
Sun, 11/3/19 - 11:23 pm
AbbVie
earnings
Humira
Imbruvica
Is AbbVie's Imbruvica concerned about AZ's rising Calquence? We've got this covered, execs say
Fierce Pharma
Fri, 11/1/19 - 06:55 pm
AbbVie
Rinvoq
AstraZeneca
Calquence
Imbruvica
Prescription drugs boost drives J&J forecasts higher, shares rise
Yahoo/Reuters
Tue, 10/15/19 - 09:52 am
JNJ
earnings
Stelara
Imbruvica
Janssen gets EC approval for two new indications of Imbruvica
Pharmaceutical Business Review
Wed, 08/14/19 - 10:17 am
JNJ
Janssen
Europe
Imbruvica
Waldenström’s macroglobulinemia
chronic lymphocytic leukemia
These 5 Prescription Drugs Will Generate a Jaw-Dropping $62.3 Billion in 2024
Yahoo/Motley Fool
Sun, 08/4/19 - 01:02 pm
Merck
Keytruda
AbbVie
Humira
Pfizer
Bristol-Myers Squibb
Eliquis
JNJ
Imbruvica
5 Things You Need to Know From AbbVie's Q2 Earnings Results
Motley Fool
Sat, 07/27/19 - 02:03 pm
AbbVie
Humira
Venclexta
Imbruvica
hepatitis C
earnings
Meet the Top Ten Drugs of 2024 (Maybe)
Drug Channels
Tue, 06/18/19 - 11:46 pm
AbbVie
Humira
Merck
Keytruda
Eliquis
Bristol-Myers Squibb
Imbruvica
Opdivo
Revlimid
Celgene
AstraZeneca's Calquence sets Imbruvica in its sights with big CLL survival numbers
Fierce Pharma
Mon, 06/17/19 - 11:21 pm
AstraZeneca
Calquence
CLL
Imbruvica
Preclinical data on MD Anderson Cancer Center-developed drug offers hope for Imbruvica-resistant mantle cell lymphoma patients
Endpoints
Sun, 05/12/19 - 01:28 pm
Imbruvica
non-Hodgkin lymphoma
mantle cell lymphoma
JNJ
MD Anderson Cancer Center
Watch out AbbVie and J&J, AstraZeneca just took another big swing at one of your star cancer drug franchises
Endpoints
Tue, 05/7/19 - 10:15 am
AstraZeneca
Calquence
clinical trials
chronic lymphocytic leukemia
AbbVie
JNJ
Imbruvica
2 Things Investors Are Missing About AbbVie
Motley Fool
Sun, 03/17/19 - 01:29 pm
AbbVie
ABBV-599
Humira
risankizumab
upadacatinib
Imbruvica
Venclexta
Orilissa
Imbruvica resistance provides early but fertile development ground
EP Vantage
Fri, 03/15/19 - 10:43 am
Arqule
Imbruvica
drug development
Btk inhibitors
FDA Gives Greenlight to Janssen and AbbVie's Imbruvica for the 10th Time
BioSpace
Mon, 01/28/19 - 12:11 pm
Imbruvica
Janssen
AbbVie
Roche
Gazyva
chronic lymphocytic leukemia
small lymphocytic lymphoma
FDA
Johnson & Johnson, AbbVie superstar Imbruvica flunks pancreatic cancer test
Fierce Pharma
Mon, 01/21/19 - 10:54 am
AbbVie
JNJ
Imbruvica
pancreatic cancer
clinical trials
AbbVie's Imbruvica misses pancreatic cancer endpoints
BioCentury
Fri, 01/18/19 - 09:16 pm
AbbVie
Imbruvica
clinical trials
PCYC-1137
metastatic pancreatic cancer
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »